secwatch.observer — SEC 8-K summary
======================================

Issuer:     Evofem Biosciences, Inc. (EVFM)
CIK:        0001618835
Form:       8-K/A
Filed at:   2023-04-12T23:59:59+00:00
Accession:  0001493152-23-011892
Event type: debt
Sentiment:  negative
Materiality: 0.60
Item codes: 1.01
LLM model:  deepseek-v4-flash:cloud@v2

Evofem Biosciences issues $769K convertible notes and warrants for ~$490K net
-----------------------------------------------------------------------------

- Aggregate $769,230.76 in senior subordinate convertible notes issued to investors.
- Warrants to purchase 76,923,077 shares of common stock issued.
- Investors paid $650 per $1,000 principal amount (~35% discount).
- Net proceeds to company after expenses approximately $490,000.
- Offering closed April 5, 2023; this 8-K/A corrects a typo in the original report.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1618835/000149315223011892/0001493152-23-011892-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1618835/000149315223011892/form8-ka.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-011892

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer